ISOSULFAN BLUE | A090874 | MYLAN INSTITUTIONAL LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| N.D. Ga. | 2025-10-13 | Terminated 2025-11-12 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Attachment 1- Orange Book Listing Lymphazurin re Suitability Petition from La... FDA-2023-P-4328 · 8 docket documents Lachman Consulting Services, Inc. filed a petition requesting that the FDA list Lymphazurin in the Orange Book as suitable for patent listing or to reconsider its current Orange Book listing status. The petition addresses the regulatory eligibility of Lymphazurin for inclusion in the official listin | Suitability | 2023-10-05 | Granted | Lachman Consulting Services, Inc |
Attachment 2 - Current Package Insert for LYMPHAZURIN, Revision 10/2007; sour... FDA-2023-P-4297 · 8 docket documents Lachman Consulting Services, Inc. filed a suitability petition regarding LYMPHAZURIN, a radiopharmaceutical product, requesting FDA assessment of the drug's suitability for a specific regulatory pathway or use. | Suitability | 2023-10-03 | Granted | Lachman Consulting Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.